Equities
Health CareMedical Equipment and Services
  • Price (JPY)2,174.50
  • Today's Change-2.50 / -0.11%
  • Shares traded905.80k
  • 1 Year change-4.98%
  • Beta0.8748
Data delayed at least 20 minutes, as of Mar 19 2024 01:50 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, science, video and other products. The Company operates in five business segments. The Endoscopy segment provides gastrointestinal endoscopy, surgical endoscopy, endoscopy systems and repair services. The Therapeutic Equipment segment provides endoscopic treatment tools, energy devices, urology, gynecology and otolaryngology products. The Scientific segment provides biological microscope, industrial microscope, industrial endoscope and non-destructive inspection equipment. The Imaging segment provides digital cameras and recording machines. The Others segment is engaged in the manufacture and sale of biomaterials. The Company is also engaged in the financial investment business.

  • Revenue in JPY (TTM)916.09bn
  • Net income in JPY39.47bn
  • Incorporated1919
  • Employees32.84k
  • Location
    Olympus CorpShinjuku Monolith, 2-3-1, Nishi-ShinjukuSHINJUKU-KU 163-0914JapanJPN
  • Phone+81 333402111
  • Fax+81 333402062
  • Websitehttps://www.olympus.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
7733:TYO since
announced
Transaction
value
Olympus Terumo Biomaterials CorpDeal completed04 Aug 202304 Aug 2023Deal completed-3.29%--
Data delayed at least 20 minutes, as of Mar 19 2024 01:50 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
APT Medical Inc31.94bn10.37bn629.04bn1.74k61.0617.01--19.697.447.4422.9326.710.67361.3732.62884,911.6021.3615.5228.0418.1870.2470.0731.7123.152.30--0.0526.8346.7451.3472.1959.6841.48--
ASAHI INTECC CO., LTD.99.01bn15.45bn774.83bn10.19k50.145.6131.287.8356.8956.89364.50508.240.60271.205.619,718,956.009.509.5711.0411.2064.6366.7815.7615.932.6166.600.052528.1315.8912.4420.715.479.128.31
Fisher & Paykel Healthcare Corporatn Ltd153.57bn23.72bn1.26tn6.56k53.067.8938.218.200.44850.44852.903.020.75561.807.85258,104.8011.6719.5313.6723.7059.6963.2715.4521.771.2994.240.155846.94-5.9810.02-33.595.6516.4413.77
Cochlear Ltd210.17bn34.26bn2.13tn4.80k62.5712.2349.8910.155.325.3232.6427.230.86021.745.14447,791.7014.028.9117.4511.6975.4674.9716.3012.191.94175.390.10490.6317.467.263.983.5814.051.92
Shanghai United Img Hlthcare Co Ltd223.93bn37.73bn2.39tn7.30k63.346.41--10.672.212.2113.1221.830.46581.424.661,480,689.007.91--10.17--49.37--16.98--2.76--0.0234--27.36--16.86------
Olympus Corp916.09bn39.47bn2.57tn32.84k66.453.3424.862.8131.83215.71741.15633.640.64051.695.4227,892,220.002.796.683.759.5367.0865.334.359.791.5812.010.288919.9717.572.3224.8319.282.1817.98
FUJIFILM Holdings Corp2.92tn239.28bn4.07tn73.88k16.471.3310.661.39596.11596.117,274.817,403.570.67152.874.8739,527,220.005.444.957.156.4840.1040.518.107.260.9053--0.1723.7813.193.283.859.2831.7211.63
Terumo Corp885.17bn99.04bn4.25tn30.21k42.753.4724.574.80132.99132.991,188.541,636.570.54721.695.3329,303,340.006.126.437.377.5151.4853.0011.1912.471.13--0.156928.2416.626.890.5765-0.435311.809.86
Hoya Corp751.55bn166.84bn6.72tn36.57k40.577.6231.118.94471.99471.992,126.342,512.990.71390.95265.5520,550,520.0015.9216.3518.4819.0985.8984.8122.3022.654.11--0.028826.029.396.202.3611.1313.247.96
Data as of Mar 19 2024. Currency figures normalised to Olympus Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

36.36%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 28 Apr 202382.91m6.82%
Baillie Gifford & Co.as of 31 Mar 202365.60m5.40%
Capital Research & Management Co. (World Investors)as of 14 Jul 202361.57m5.07%
The Vanguard Group, Inc.as of 07 Mar 202442.13m3.47%
Nikko Asset Management Co., Ltd.as of 08 Mar 202439.35m3.24%
BlackRock Fund Advisorsas of 31 Oct 202236.93m3.04%
Daiwa Asset Management Co. Ltd.as of 29 Feb 202435.94m2.96%
Norges Bank Investment Managementas of 31 Dec 202330.36m2.50%
BlackRock Japan Co. Ltd.as of 31 Oct 202226.96m2.22%
Mitsubishi UFJ Asset Management Co., Ltd.as of 11 Sep 202320.10m1.65%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.